[Congressional Record Volume 171, Number 47 (Wednesday, March 12, 2025)]
[Senate]
[Pages S1718-S1721]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]
SA 1260. Mr. CORNYN submitted an amendment intended to be proposed by
him to the bill S. 331, to amend the Controlled Substances Act with
respect to the scheduling of fentanyl-related substances, and for other
purposes; which was ordered to lie on the table; as follows:
At the appropriate place, insert the following:
SEC. ___. OFFICE OF NATIONAL DRUG CONTROL POLICY
REAUTHORIZATION.
(a) Amendments to the Office of National Drug Control
Policy Reauthorization Act of 1998.--The Office of National
Drug Control Policy Reauthorization Act of 1998 (21 U.S.C.
1701 et seq.) is amended--
(1) in section 702 (21 U.S.C. 1701)--
(A) in paragraph (3)--
(i) in subparagraph (L), by striking ``; and'' and
inserting a semicolon;
(ii) in subparagraph (M), by striking the period at the end
and inserting ``; and''; and
(iii) by adding at the end the following:
``(N) tertiary prevention support or services, including
opioid antagonists or overdose reversal agents such as
naloxone, and other harm reduction activities such as
overdose and drug detection testing.'';
(B) by amending paragraph (7) to read as follows:
``(7) Emerging drug threat.--The term `emerging drug
threat' means the occurrence of a new and growing trend in
the illicit use or misuse of a drug, class of drugs, or non-
controlled substance, or a new or evolving method of drug
consumption or trafficking, including rapid expansion in the
supply of or demand for such a drug or substance.''.
(C) in paragraph (9), by striking ``drug laws'' and
inserting the following: ``drug, trade, and illicit drug
trafficking laws'';
(D) in paragraph (10), by inserting after ``demand
reduction,'' the following: ``illicit drug trafficking,'';
(E) by redesignating paragraphs (15), (16), and (17) as
paragraphs (17), (18), and (19), respectively;
(F) by inserting after paragraph (14) the following new
paragraph:
``(15) Precursor chemical.--
``(A) In general.--The term `precursor chemical' includes a
listed chemical and an unregulated precursor.
``(B) Listed chemical.--The term `listed chemical' has the
meaning given that term in section 102 of the Controlled
Substances Act (21 U.S.C. 802).
``(C) Unregulated precursor.--The term `unregulated
precursor'--
``(i) means any chemical used in the production of illicit
drugs that has not been identified as a listed chemical under
the Controlled Substances Act (21 U.S.C. 801 et seq.); and
``(ii) does not include a solvent or reagent.
``(16) State.--The term `State' means each of the several
States of the United States, the District of Columbia, and
each territory or possession of the United States.'';
(G) in paragraph (19), as so redesignated--
(i) by redesignating subparagraphs (G) and (H) as
subparagraphs (H) and (I), respectively; and
(ii) by inserting after subparagraph (F) the following:
``(G) activities to map, track, dismantle, and disrupt the
financial enablers of drug trafficking organizations,
transnational criminal organizations, and money launderers
involved in the manufacture and trafficking of drugs in the
United States and in foreign countries;''; and
(H) by inserting at the end the following:
``(20) United states.--The term `United States', when used
in a geographical sense, means all of the States, the
District of Columbia, and the territories and possessions of
the United States, and any waters within the jurisdiction of
the United States.
``(21) Evidence.--The term `evidence' has the meaning given
that term in section 3561 of title 44, United States Code.'';
(2) in section 703(d) (21 U.S.C. 1702(d))--
(A) in paragraph (5)(B), by striking ``accepted by a
contractor to be used in its performance of a contract for
the Office.'' and inserting the following: ``accepted--
``(i) by a contractor (or subcontractor thereof at any
tier) for use in its performance of a contract for the
Office; or
``(ii) by a grant recipient (or subgrantee thereof at any
tier) for use in carrying out an award related to a fund
administered by the Office.''; and
(B) in paragraph (6), by inserting after ``paragraph (5)''
the following: ``and the registry shall be sent to the
appropriate congressional committees'';
(3) in section 704 (21 U.S.C. 1703)--
(A) in subsection (a)(1)(C), by striking ``shall'' and
inserting ``may'';
(B) in subsection (b)--
(i) in paragraph (16), by inserting after ``to treat
addiction'' the following: ``, encourage primary substance
use prevention, and increase accessibility and effectiveness
of life-saving opioid antagonists or reversal agents, such as
naloxone'';
(ii) by striking paragraph (20);
(iii) by redesignating paragraph (21) as paragraph (20);
(iv) in paragraph (20), as so redesignated, by striking the
period at the end and inserting ``; and''; and
(v) by adding at the end the following:
``(21) shall coordinate with the Secretary of Homeland
Security, the Attorney General, and the Secretary of State
regarding the status of the enforcement of clauses (i) and
(ii) of subparagraph (A) and subparagraph (B) of section
237(a)(2) of the Immigration and Nationality Act (8 U.S.C.
1227(a)(2)) and subparagraphs (A) and (C) of section
212(a)(2) of that Act (8 U.S.C. 1182(a)(2)) for the purposes
of ensuring such drug control and illicit drug trafficking
enforcement activities are adequately resourced.'';
(C) in subsection (c)--
(i) in paragraph (1)(C), by striking ``supply reduction,
and State, local, and tribal affairs, including any drug law
enforcement activities'' and inserting the following:
``supply reduction, accessibility to life-saving opioid
antagonists or reversal agents, such as naloxone, and State,
local, and Tribal affairs, including any drug related law
enforcement activities'';
(ii) in paragraph (3)(C)--
(I) in clause (ii), by inserting after ``United States''
the following: ``, including at and between the ports of
entry,'';
(II) in clause (iii), by striking ``; and'' and inserting a
semicolon;
(III) in clause (iv), by striking the period at the end and
inserting ``; and''; and
(IV) by adding at the end the following:
``(v) requests funding for activities that facilitate
illicit drug use, but not including overdose reversal
medications, drug checking, or testing technology.'';
(D) in subsection (d)(8)(F)(ii), by striking ``and at
United States ports of entry by officers and employees of
National Drug Control Program agencies and domestic and
foreign law enforcement officers'' and inserting the
following: ``and at and between United States ports of entry
by officers and employees of National Drug Control Program
agencies and domestic and foreign law enforcement officers'';
(E) in subsection (i)--
(i) in paragraph (1)(A), by striking ``to address illicit
drug use issues'' and inserting the following: ``to address
illicit drug use, prevention and treatment of overdose and
addiction, and law enforcement activities''; and
(ii) in paragraph (2), by striking ``2023'' and inserting
``2031''; and
(F) in subsection (k)--
(i) in the heading, by striking ``Harm Reduction Programs''
and inserting ``Substance Use Prevention, Harm Reduction, and
Life-saving Treatment Programs''; and
(ii) in the first sentence, by inserting after ``drug
addiction and use'' the following: ``with the primary goal
being the prevention of initial or continued use and the
fostering of life-saving opioid antagonists or reversal
agents, such as naloxone'';
(4) in section 705 (21 U.S.C. 1704)--
(A) in subsection (a)(3)--
(i) in subparagraph (A), by inserting after ``Federal
Government'' the following: ``and such lands owned by a
foreign principal (as such term in defined in section 1(b) of
the Foreign Agents Registration Act of 1938, as amended (22
U.S.C. 611(b)))'';
(ii) in subparagraph (B)--
(I) in the matter preceding clause (i), by inserting after
``the preceding year'' the following: ``, along with
historical comparisons over the prior 20 years,'';
(II) in clause (i)--
(aa) by inserting after ``seizing drugs,'' the following:
``including precursor chemicals,''; and
(bb) by striking ``; and'' and inserting a semicolon;
(III) in clause (ii), by striking the period at the end and
inserting ``; and''; and
(IV) by adding at the end the following:
``(iii) the effects of trends of encounters of inadmissible
aliens at and between the ports of entry, and the effect of
any increases or changes in the level of trade and travel, on
the capacity and ability of the Department of Homeland
Security components to interdict and prevent the unlawful
entry of illicit
[[Page S1719]]
drugs into the United States by any means.''; and
(iii) in subparagraph (D)--
(I) in the matter preceding clause (i), by inserting after
``the preceding year'' the following: ``, along with
historical comparisons over the prior 20 years,''; and
(II) in clause (iii), by inserting after ``seizing drugs,''
the following: ``including precursor chemicals,'';
(B) in subsection (e)(2), by inserting before the period at
the end the following: ``and $3,000,000 for each of fiscal
years 2025 through 2031''; and
(C) in subsection (f)--
(i) in paragraph (2), by inserting after ``agency shall''
the following: ``, in accordance with guidelines issued by
the Director for standard definitions, identification, and
review procedures,''; and
(ii) by striking paragraph (4);
(5) in section 706 (21 U.S.C. 1705)--
(A) in subsection (c)--
(i) in paragraph (1)--
(I) by striking subparagraph (D);
(II) in subparagraph (H)--
(aa) by inserting after ``identifying existing'' the
following: ``evidence and''; and
(bb) by striking ``will obtain such data'' and inserting
``will ensure such data is obtained'';
(III) in subparagraph (J)(ii), by inserting ``evidence,''
before ``data'';
(IV) in subparagraph (L), by striking ``statistical data''
and inserting ``evidence, statistical data,''; and
(V) in subparagraph (M)(iv), by inserting ``storing and
retrieving,'' after ``collecting,'';
(ii) in paragraph (2)--
(I) by redesignating subparagraphs (E) and (F) as
subparagraphs (G) and (H), respectively; and
(II) by inserting after subparagraph (D) the following:
``(E) The Administrator of the Office of Information and
Regulatory Affairs.
``(F) The Chief Data Officers Council.'';
(iii) in paragraph (3)--
(I) in subparagraph (B)(ii)--
(aa) in subclause (I), by striking ``; and'' and inserting
a semicolon;
(bb) in subclause (II), by striking the period at the end
and inserting ``; and''; and
(cc) by adding at the end the following:
``(III) an analysis of the effects of trends of encounters
of inadmissible aliens at and between the ports of entry, and
the effect of any increases or changes in the level of trade
and travel, on the capacity and ability of the Department of
Homeland Security to interdict and prevent the unlawful entry
of illicit drugs into the United States by any means.''; and
(II) by adding at the end the following:
``(D) Requirement for caribbean border counternarcotics
strategy.--
``(i) Purposes.--The Caribbean Border Counternarcotics
Strategy shall--
``(I) set forth the strategy of the Federal Government for
preventing the illegal trafficking of drugs through the
Caribbean region into the United States, including through
ports of entry, between ports of entry, and across air and
maritime approaches;
``(II) state the specific roles and responsibilities of
each relevant National Drug Control Program agency for
implementing the strategy;
``(III) identify the specific resources required to enable
the relevant National Drug Control Program agencies to
implement the strategy, to the extent practicable; and
``(IV) be designed to promote, and not hinder, legitimate
trade and travel.
``(ii) Specific content related to puerto rico and the
united states virgin islands.--The Caribbean Border
Counternarcotics Strategy shall include--
``(I) a strategy to prevent the illegal trafficking of
drugs to or through Puerto Rico and the United States Virgin
Islands, including measures to substantially reduce drug-
related violent crime on such islands; and
``(II) recommendations for additional assistance or
authorities, if any, needed by Federal, State, and local law
enforcement agencies relating to the strategy, including an
evaluation of Federal technical and financial assistance,
infrastructure capacity building, and interoperability
deficiencies.''; and
(iv) in paragraph (5), by striking ``data'' each place it
appears and inserting ``evidence, data,'';
(B) in subsection (f)--
(i) in paragraph (1), by striking ``publicly available in a
machine-readable format'' and inserting the following:
``publicly available as an open Government data asset (as
such term is defined in section 3502 of title 44, United
States Code)'';
(ii) in paragraph (2), by inserting after ``searchable
format'' the following: ``available for bulk download to the
extent practicable''; and
(iii) by amending paragraph (3) to read as follows:
``(3) Data.--The data included in the Drug Control Data
Dashboard shall be updated annually with final data, and to
the extent practicable, updated quarterly with provisional
data, that aligns with the goals of the performance
measurement system required under subsection (h) and include,
at a minimum, the following:
``(A) For each substance identified by the Director as
having a significant impact on illicit drug use in the United
States, data sufficient to--
``(i) assess supply reduction efforts, including, to the
extent practicable, the total amount of substances seized;
``(ii) assess drug use behaviors;
``(iii) estimate the prevalence of substance use disorders;
``(iv) show the number of fatal and non-fatal overdoses;
and
``(v) assess the provision of substance use disorder
treatment.
``(B) Any quantifiable measures the Director determines to
be appropriate to detail progress toward the achievement of
the goals of the National Drug Control Strategy, including,
to the extent practicable, data disaggregated by specific
geographic areas or sub-populations of interest.
``(C) Data sufficient to assess the effectiveness of such
substance use disorder treatments.
``(D) To the extent practicable, data sufficient to show
the extent of prescription drug diversion, trafficking, and
misuse in the calendar year and each of the previous 3
calendar years.
``(E) Any quantifiable measures the Director determines to
be appropriate to detail progress toward the achievement of
the goals of the National Drug Control Strategy, including to
the extent practicable, data disaggregated by specific
geographic areas or sub-populations of interest.''; and
(C) in subsection (g)(2)--
(i) in subparagraph (D), by striking ``narcotics'' and
inserting ``drugs'';
(ii) in subparagraph (E), by striking ``drug use'' and
inserting ``illicit drug use and misuse''; and
(iii) in subparagraph (F), by striking ``drug use'' and
inserting ``illicit drug use and misuse'';
(6) in section 707 (21 U.S.C. 1706)--
(A) in subsection (l)(2)(F), by inserting ``and authorities
enforcing illicit drug trafficking laws'' after ``task
forces'';
(B) in subsection (m)(2), by inserting ``, and authorities
enforcing illicit drug trafficking laws,'' after
``agencies'';
(C) in subsection (p)--
(i) in paragraph (5), by striking ``; and'' and inserting a
semicolon;
(ii) in paragraph (6), by striking the period at the end
and inserting ``; and''; and
(iii) by adding at the end the following:
``(7) $298,579,000 for each of fiscal years 2025 through
2031.'';
(D) in subsection (r)(3), by striking ``addiction'';
(E) in subsection (s)--
(i) in the matter preceding paragraph (1), by striking
``The Director'' and inserting ``Except as provided in
subsection (t)(2), the Director'';
(ii) in paragraph (2), by striking ``; and'' and inserting
a semicolon;
(iii) in paragraph (3), by striking the period at the end
and inserting ``; and''; and
(iv) by adding at the end the following:
``(4) enhancing fentanyl seizure and interdiction
activities.''; and
(F) by adding at the end the following:
``(t) Supplemental Grants for Fentanyl Interdiction
Activities.--
``(1) Minimum allocation of funds for fentanyl interdiction
activities.--Of the amounts allocated for grants under
subsection (s), not less than $5,000,000 shall be allocated
for the purpose of making grants under subsection (s)(4).
``(2) Additional funds.--In addition to amounts allocated
under subparagraph (A) for the purpose of making grants under
subsection (s)(4), the Director may use amounts otherwise
appropriated to carry out this section for such purpose.
``(u) Additional Judiciary Prosecutorial Resources.--
``(1) Temporary reassignment of assistant united states
attorneys.--
``(A) Authority.--The Attorney General may identify
assistant United States attorneys who may be made available
for temporary reassignment under subsection (b)(2) for a
period of time determined by the Attorney General in
coordination with the Director, during which an assistant
United States attorney shall prioritize the investigation and
prosecution of organizations and individuals trafficking in
fentanyl or fentanyl analogues.
``(B) Extension of reassignment.--Such reassignment may be
extended by the Attorney General for such time as may be
necessary to conclude any ongoing investigation or
prosecution in which the assistant United States attorney is
engaged.
``(2) Process for temporary reassignment.--The Attorney
General may establish a process under which the Director, in
consultation with the Executive Boards of each designated
high intensity drug trafficking area, may request such an
assistant United States attorney to be so temporarily
reassigned.
``(v) Use of Funds To Combat Fentanyl Trafficking.--
``(1) Requirement.--As part of the documentation that
supports the President's annual budget request for the
Office, the Director shall submit to Congress a report
describing the use of HIDTA funds for the purposes of
enhancing fentanyl seizure and interdiction activities under
subsection (s)(4) or (t) and to investigate and prosecute
organizations and individuals trafficking in fentanyl or
fentanyl analogues in the prior calendar year.
``(2) Contents.--The report shall include--
``(A) the amounts of fentanyl or fentanyl analogues seized
by HIDTA-funded initiatives in the area during the previous
year; and
[[Page S1720]]
``(B) law enforcement intelligence and predictive data from
the Drug Enforcement Administration showing patterns and
trends in abuse, trafficking, and transportation in fentanyl
and fentanyl analogues.
``(w) Protection From Unreasonable Search and Seizure.--Any
program or activity that receives funds made available under
this section shall be conducted in a manner consistent with
the requirements of the Fourth Amendment to the Constitution
of the United States.
``(x) Report on Data Analytical Services Program.--
``(1) Report.--With respect to the Data Analytical Services
program (formally known as Hemisphere), and any successor
program, the Director shall submit to the Committee on
Oversight and Government Reform and the Committee on the
Judiciary of the House of Representatives, and the Committee
on the Judiciary of the Senate, a report every 2 years on any
activities of the program--
``(A) funded by the Office; and
``(B) carried out in 2 years prior to the submission of the
report.
``(2) Contents of report.--The report required by paragraph
(1) shall include the following:
``(A) A documentation of any activities of the Data
Analytical Services program, including--
``(i) the amount of searches conducted for each HIDTA; and
``(ii) each requesting local law enforcement jurisdiction.
``(B) Information on how the program was funded and how
funds were expended under the program, including information
on any--
``(i) funding sources derived from each HIDTA's funding
allocation for a HIDTA, or any other source of funding, for
the program; and
``(ii) payments made by the program to any non-governmental
entity or external vendor.
``(C) A description of any policies and guidelines provided
to HIDTA personnel and local law enforcement jurisdictions
governing the operation of the program in order to ensure
that such program does not infringe on rights protected under
the Fourth Amendment to the Constitution of the United States
or violate legally protected privacy of United States
citizens or individuals legally in the United States, along
with any recommendations by the Director to strengthen such
policies and guidelines.'';
(7) in section 709 (21 U.S.C. 1708)--
(A) in subsection (f)--
(i) in paragraph (1)--
(I) in the matter preceding subparagraph (A), by striking
``shall'' and inserting ``may'';
(II) in subparagraph (A), by striking ``abuse'' and
inserting ``use or misuse''; and
(III) in subparagraph (D)(i), by striking ``addiction
issues'' and inserting ``substance use disorders''; and
(ii) in paragraph (2)(B)(iii)(IV), by inserting after
``professionals'' the following: ``including experts in
evidence-based media campaigns, education, and evaluation'';
and
(B) in subsection (g), by striking ``2023'' and inserting
``2031'';
(8) in section 711 (21 U.S.C. 1710), including the
headings, by striking ``Command and Control Plan'' each place
it appears and inserting ``Strategic Plan''; and
(9) in section 714 (21 U.S.C. 1711), by inserting before
the period at the end the following: ``and $20,000,000 for
each of fiscal years 2025 through 2031''.
(b) Amendments to the Anti-Drug Abuse Act of 1988.--Chapter
2 of subtitle A of title I of the Anti-Drug Abuse Act of 1988
(21 U.S.C. 1521 et seq.) is amended--
(1) in section 1024 (21 U.S.C. 1524)--
(A) in subsection (a), by inserting before the period at
the end the following: ``and $109,000,000 for each of fiscal
years 2025 through 2031''; and
(B) in subsection (b), by striking ``8 percent'' and
inserting ``10 percent''; and
(2) in section 1032(b) (21 U.S.C. 1532(b))--
(A) by striking ``$125,000'' each place the term appears
and inserting ``$150,000''; and
(B) in paragraph (3)--
(i) by striking subparagraph (A) and inserting the
following:
``(A) In general.--Subject to subparagraph (F), the
Administrator may award up to 2 additional grants under this
paragraph to an eligible coalition awarded a grant under
paragraph (1) or (2) for any first fiscal year after the end
of the 4-year or 9-year period following the period of the
initial or subsequent grant under paragraph (1) or (2), as
the case may be.'';
(ii) in subparagraph (B), by striking ``a renewal grant''
and inserting ``up to 2 renewal grants'';
(iii) in subparagraph (C), by striking ``an additional
grant'' and inserting ``the additional grants''; and
(iv) by striking subparagraph (D) and inserting the
following:
``(D) Renewal grants.--Subject to subparagraph (F), the
Administrator may award a renewal grant to a grant recipient
under this paragraph for each fiscal year of the 4-fiscal-
year period following the first fiscal year for which an
additional grant under this paragraph is awarded in an amount
not to exceed the amount of non-Federal funds raised by the
coalition, including in-kind contributions, for that fiscal
year.''.
(c) Reauthorization of the National Community Anti-Drug
Coalition Institute.--Section 4(d) of Public Law 107-82 (21
U.S.C. 1521 note) is amended by striking paragraph (2) and
inserting the following:
``(2) Disbursement.--The Director shall, using amounts
authorized to be appropriated by section 1024 of the Anti-
Drug Abuse Act of 1988 (21 U.S.C. 1524), disburse $2,500,000
made available under subsection (a) of this section, for each
of fiscal years 2025 through 2031.''.
(d) Reauthorization of Community-based Coalition
Enhancement Grants to Address Local Drug Crises.--Section 103
of the Comprehensive Addiction and Recovery Act of 2016 (21
U.S.C. 1536) is amended--
(1) in subsection (a)--
(A) in paragraph (1)--
(i) in the heading, by striking ``Administrator'' and
inserting ``assistant secretary'';
(ii) by striking ``Administrator'' each place it appears
and inserting ``Assistant Secretary''; and
(iii) by striking ``of the Substance Abuse and Mental
Health Services Administration'' and inserting ``for Mental
Health and Substance Use'';
(B) in paragraph (4)(B), in the matter preceding clause
(i), by striking ``abuse'' and inserting ``use or misuse'';
and
(C) in paragraph (5)(A), by striking ``abuse'' and
inserting ``use or misuse'';
(2) in subsection (b), by striking ``Administrator'' and
inserting ``Assistant Secretary'';
(3) in subsection (h), by striking ``Administrator'' and
inserting ``Assistant Secretary''; and
(4) in subsection (i), by inserting before the period at
the end the following: ``and $5,200,000 for each of fiscal
years 2025 through 2031''.
(e) Report Regarding Life-saving Opioid Antagonists or
Reversal Agents.--
(1) Amendment.--The Office of National Drug Control Policy
Reauthorization Act of 2006 (Public Law 109-469; 120 Stat.
3502) is amended by adding at the end the following:
``SEC. 1121. REQUIREMENT FOR LIFE SAVING OPIOID OVERDOSE
REVERSAL STUDY.
``(a) Finding.--Congress finds that it is vital to support
access to treatment and emergency intervention tools to
address drug addiction while also pursuing strategies to
ensure communities have readily available access to life-
saving drug overdose reversal medications, including opioid
antagonists or reversal agents, such as naloxone, in case of
an emergency.
``(b) Report.--Not later than 180 days after the date of
enactment of this section, the Director of the Office of
National Drug Control Policy shall submit to Congress a
report that contains the following:
``(1) A summary of the relevant roles, responsibilities,
and authorities of each relevant National Drug Control
Program agency to ensure that life-saving drug overdose
reversal medications are readily available in case of an
emergency, including life-saving opioid antagonists or
reversal agents, such as naloxone, across the United States.
``(2) A strategy for the Federal Government to ensure that
State, local, and Tribal governments, and agencies thereof
including law enforcement and public health and safety
entities, have life-saving drug overdose reversal medications
readily available in case of an emergency, including life-
saving opioid antagonists or reversal agents, such as
naloxone, which at a minimum identifies--
``(A) any Federal and State policies and actions necessary
for the relevant National Drug Control Program agencies to
take to address--
``(i) the challenges faced by pharmacists, prescription
drug providers, dispensers (including manufacturers,
distributors, and retailers), and other health care
providers, to make such medications readily available to
patients over the counter for emergency use;
``(ii) the challenges faced by pharmacists, health care
providers, and State health officials to educate the public
on the risks and benefits of such medications, including how
to effectively use such medications; and
``(iii) the appropriate training of State and local health
care providers and first responders on the use of such
medications; and
``(B) identifies any budgetary resources, personnel
resources, licensing requirements, and legal authorities that
relevant National Drug Control Program agencies need to
enable the availability of such life-saving emergency drug
overdose medications.
``(3) A summary of policies in effect before the submission
of the report that are administered by--
``(A) the Director of the Office of National Drug Control
Policy;
``(B) the Secretary of Health and Human Services; and
``(C) each National Drug Control Program agency, as
applicable.
``(4) A summary of the specific actions taken over the
previous 10 years before the submission of the report by the
Substance Abuse and Mental Health Services Administration and
the Drug Enforcement Administration to coordinate with one
another and with State health agencies to ensure that--
``(A) such treatments, including medications, are
accessible to the public; and
``(B) appropriate public education on the use of, and the
risks and benefits of, such treatments, including
medications, are readily available.
``(c) Updates.--Any significant update made to the strategy
included in the report required by subsection (b) after such
report is submitted shall be included in the next National
Drug Control Strategy submitted to Congress after such update
is made.''.
(2) Technical and conforming amendment.--The table of
contents in section 1(c)
[[Page S1721]]
of the Office of National Drug Control Policy Reauthorization
Act of 2006 (Public Law 109-469; 120 Stat. 3502) is amended
by adding at the end the following:
``Sec. 1121. Requirement for life saving opioid overdose reversal
study.''.
(f) Report on Pill Press Machines.--Not later than 120 days
after the date of enactment of this Act, the Director of the
Office of National Drug Control Policy shall make public a
report that includes an analysis of and a description of
strategic ways to regulate the shipment of pill press
machines and their critical parts using reports previously
prepared by the Office.
______